SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
11.05
+0.01 (0.09%)
At close: Aug 11, 2026, 4:00 PM EDT
11.06
+0.01 (0.06%)
After-hours: Aug 11, 2026, 7:59 PM EDT

SLS Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-32.46-26.86-30.88-37.34-41.3-20.7
Stock-Based Compensation
2.761.961.562.091.731.01
Other Adjustments
0.610.60.560.4910.131.28
Change in Receivables
-----1.13
Changes in Accounts Payable
-0.23-0.54-2.142.31.21-2.51
Changes in Accrued Expenses
1.82-1.94-2.181.453.650.73
Changes in Unearned Revenue
------5.6
Changes in Other Operating Activities
-0.92-1.6-2.32-0.410.78-1.36
Operating Cash Flow
-28.42-28.39-35.4-31.41-23.81-26.02
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Purchases of Intangible Assets
----5.5-4.5-
Investing Cash Flow
----5.5-4.5-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
90.9586.8246.8222.3524.0812.07
Repurchase of Common Stock
--0.53-0.06-0.03--
Net Common Stock Issued (Repurchased)
90.9586.346.7622.3224.0812.07
Financing Cash Flow
141.4786.346.7622.3224.0812.07

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
113.0557.9111.36-14.6-4.23-13.95

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-28.42-28.39-35.4-31.41-23.81-26.02
Free Cash Flow Growth
------
FCF Margin
-----2380.90%-342.38%
Free Cash Flow Per Share
-0.19-0.26-0.58-1.13-1.23-1.68
Levered Free Cash Flow
-31.79-30.94-37.53-34-35.66-29.44
Unlevered Free Cash Flow
-34.55-32.35-38.16-34.52-36.31-33.75
SEC Filings: 10-K · 10-Q